Literature DB >> 23263555

Absence of signaling into CD4⁺ cells via C3aR and C5aR enables autoinductive TGF-β1 signaling and induction of Foxp3⁺ regulatory T cells.

Michael G Strainic1, Ethan M Shevach, Fengqi An, Feng Lin, M Edward Medof.   

Abstract

Signaling through the G protein-coupled receptors for the complement fragments C3a and C5a (C3aR and C5aR, respectively) by dendritic cells and CD4(+) cells provides costimulatory and survival signals to effector T cells. Here we found that when signals from C3aR and C5aR were not transduced into CD4(+) cells, signaling via the kinases PI(3)Kγ, Akt and mTOR ceased, activation of the kinase PKA increased, autoinductive signaling by transforming growth factor-β1 (TGF-β1) initiated and CD4(+) T cells became Foxp3(+) induced regulatory T cells (iT(reg) cells). Endogenous TGF-β1 suppressed signaling through C3aR and C5aR by preventing the production of C3a and C5a and upregulating C5L2, an alternative receptor for C5a. The absence of signaling via C3aR and C5aR resulted in lower expression of costimulatory molecules and interleukin 6 (IL-6) and more production of IL-10. The resulting iT(reg) cells exerted robust suppression, had enhanced stability and suppressed ongoing autoimmune disease. Antagonism of C3aR and C5aR can also induce functional human iT(reg) cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23263555      PMCID: PMC4144047          DOI: 10.1038/ni.2499

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  48 in total

1.  A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells.

Authors:  M Ohno; T Hirata; M Enomoto; T Araki; H Ishimaru; T A Takahashi
Journal:  Mol Immunol       Date:  2000-06       Impact factor: 4.407

2.  Evidence for a functional role of the second C5a receptor C5L2.

Authors:  Hongwei Gao; Thomas A Neff; Ren-Feng Guo; Cecilia L Speyer; J Vidya Sarma; Scott Tomlins; Yunfang Man; Niels C Riedemann; L Marco Hoesel; Ellen Younkin; Firas S Zetoune; Peter A Ward
Journal:  FASEB J       Date:  2005-03-22       Impact factor: 5.191

3.  An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2.

Authors:  Norma P Gerard; Bao Lu; Pixu Liu; Stewart Craig; Yuko Fujiwara; Shoji Okinaga; Craig Gerard
Journal:  J Biol Chem       Date:  2005-10-04       Impact factor: 5.157

4.  C5L2 receptor is not involved in C3a / C3a-desArg-mediated enhancement of bone marrow hematopoietic cell migration to CXCL12.

Authors:  M Honczarenko; B Lu; A Nicholson-Weller; N P Gerard; L E Silberstein; C Gerard
Journal:  Leukemia       Date:  2005-09       Impact factor: 11.528

Review 5.  Complement and Toll-like receptors: key regulators of adaptive immune responses.

Authors:  Heiko Hawlisch; Jörg Köhl
Journal:  Mol Immunol       Date:  2006-01       Impact factor: 4.407

6.  Promoter sequences of the human transforming growth factor-beta 1 gene responsive to transforming growth factor-beta 1 autoinduction.

Authors:  S J Kim; K T Jeang; A B Glick; M B Sporn; A B Roberts
Journal:  J Biol Chem       Date:  1989-04-25       Impact factor: 5.157

7.  Complement c3a and c5a induce different signal transduction cascades in endothelial cells.

Authors:  Ingrid U Schraufstatter; Khanh Trieu; Lyudmila Sikora; P Sriramarao; Richard DiScipio
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

Review 8.  A complex interplay between Akt, TSC2 and the two mTOR complexes.

Authors:  Jingxiang Huang; Brendan D Manning
Journal:  Biochem Soc Trans       Date:  2009-02       Impact factor: 5.407

9.  C5L2, a nonsignaling C5A binding protein.

Authors:  Shoji Okinaga; Dubhfeasa Slattery; Alison Humbles; Zsusanna Zsengeller; Olivier Morteau; Michele Bennett Kinrade; Robbin M Brodbeck; James E Krause; Hye-Ryun Choe; Norma P Gerard; Craig Gerard
Journal:  Biochemistry       Date:  2003-08-12       Impact factor: 3.162

10.  Autoinduction of mRNA and protein expression for transforming growth factor-beta S in cultured cardiac cells.

Authors:  K C Flanders; M G Holder; T S Winokur
Journal:  J Mol Cell Cardiol       Date:  1995-02       Impact factor: 5.000

View more
  145 in total

Review 1.  Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective.

Authors:  M A Khan; J L Hsu; A M Assiri; D C Broering
Journal:  Clin Exp Immunol       Date:  2015-11-05       Impact factor: 4.330

2.  CD55 Is Essential for CD103+ Dendritic Cell Tolerogenic Responses that Protect against Autoimmunity.

Authors:  Michael G Strainic; Jinbo Liu; Fengqi An; Erin Bailey; Andrew Esposito; Jörg Hamann; Peter S Heeger; M Edward Medof
Journal:  Am J Pathol       Date:  2019-05-17       Impact factor: 4.307

Review 3.  Complement: an overview for the clinician.

Authors:  Juan Carlos Varela; Stephen Tomlinson
Journal:  Hematol Oncol Clin North Am       Date:  2015-04-04       Impact factor: 3.722

4.  Absence of recipient C3aR1 signaling limits expansion and differentiation of alloreactive CD8+ T cell immunity and prolongs murine cardiac allograft survival.

Authors:  Douglas R Mathern; Julian K Horwitz; Peter S Heeger
Journal:  Am J Transplant       Date:  2019-01-14       Impact factor: 8.086

5.  The receptor for the complement C3a anaphylatoxin (C3aR) provides host protection against Listeria monocytogenes-induced apoptosis.

Authors:  Stacey L Mueller-Ortiz; John E Morales; Rick A Wetsel
Journal:  J Immunol       Date:  2014-06-30       Impact factor: 5.422

Review 6.  Molecules Great and Small: The Complement System.

Authors:  Douglas R Mathern; Peter S Heeger
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 8.237

7.  Complement Dependence of Murine Costimulatory Blockade-Resistant Cellular Cardiac Allograft Rejection.

Authors:  N Chun; R L Fairchild; Y Li; J Liu; M Zhang; W M Baldwin; P S Heeger
Journal:  Am J Transplant       Date:  2017-05-30       Impact factor: 8.086

8.  Defective TGF-β signaling in bone marrow-derived cells prevents hedgehog-induced skin tumors.

Authors:  Qipeng Fan; Dongsheng Gu; Hailan Liu; Ling Yang; Xiaoli Zhang; Mervin C Yoder; Mark H Kaplan; Jingwu Xie
Journal:  Cancer Res       Date:  2013-11-26       Impact factor: 12.701

Review 9.  Ubiquitous points of control over regulatory T cells.

Authors:  Fan Pan; Joseph Barbi
Journal:  J Mol Med (Berl)       Date:  2014-04-29       Impact factor: 4.599

Review 10.  Complement and Transplantation: From New Mechanisms to Potential Biomarkers and Novel Treatment Strategies.

Authors:  Julian K Horwitz; Nicholas H Chun; Peter S Heeger
Journal:  Clin Lab Med       Date:  2018-12-20       Impact factor: 1.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.